Amy Billet's clinical research focuses on childhood lymphoma. She is a member of a small national consortium dedicated to improving the long-term outcome for children with Hodgkin disease. She is on the faculty of a national quality improvement collaborative focused on reducing catheter-associated blood-stream infections in pediatric hematology/oncology patients. She has had a long term involvement in electronic health record implementation to improve patient safety. She is co-principal investigator of several ongoing patient safety studies.
About Amy Billett
Dr. Billett received her MD from Harvard Medical School. She completed a residency in pediatrics at the University of Washington Hospitals and a fellowship in pediatric hematology/oncology at Boston Children's Hospital and Dana-Farber Cancer Institute.